measuregroup/AID1919575

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID384577831_AID1919575_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442073771_AID1919575_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442073771_AID1919575_PMID_VALUE7 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID384577831_AID1919575_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID384577831_AID1919575_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442073771_AID1919575_PMID_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442073771_AID1919575_PMID_VALUE8 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID384577831_AID1919575_PMID_VALUE2
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52333 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29597 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60674 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23458
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	LanthaScreen JAK Biochemical Assays (JAK1, 2, 3 and Tyk2) from US Patent US11702415: \"Crystalline hydrate of a JAK inhibitor compound\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID384577831 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442073771
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1919575

Total number of triples: 18.